R. L. Tassell

The enterotoxin of Bacteroides fragilis is a metalloprotease

T. Wilkins, R. Van Tassell, D. Lyerly, 1995, Infection and immunity.

CHAPTER 12 – Production of Intestinal Mutagens

T. Wilkins, R. L. V. Tassell, R. L. Tassell, 1983 .

Metabolism of levamisole, an anti-colon cancer drug, by human intestinal bacteria.

Y. Shu, D. Kingston, T. Wilkins, 1991, Xenobiotica; the fate of foreign compounds in biological systems.

Proteolytic activity of the Bacteroides fragilis enterotoxin causes fluid secretion and intestinal damage in vivo

T. Wilkins, R. Van Tassell, D. Lyerly, 1995, Infection and immunity.

Production of Clostridium difficile antitoxin

M. Ehrich, J. Libby, T. Wilkins, 1980, Infection and immunity.

Isolation and structure elucidation of plasmalopentaene-12, the biological precursor of fecapentaene-12

D. Kingston, C. Duh, T. Wilkins, 1989 .

The precursors of fecapentaenes: Purification and properties of a novel plasmalogen

D. Kingston, T. Wilkins, T. Piccariello, 1989, Lipids.

Structure elucidation of a potent mutagen from human feces

D. Kingston, T. Wilkins, N. Hirai, 1982 .

Mutagens in the feces of 3 South-African populations at different levels of risk for colon cancer.

M. Ehrich, T. Wilkins, A. Walker, 1979, Mutation research.